Anissa Daliry

Hepatic microvascular dysfunction and increased advanced glycation end products are components of non-alcoholic fatty liver disease

Evelyn Nunes Goulart da Silva Pereira, Raquel Rangel Silvares, Edgar Eduardo Ilaquita Flores et al. · PLoS ONE · 2017 · 63 citations · Full text

Experimental chemotherapy for Chagas disease: 15 years of research contributions from in vivo and in vitro studies

Maria de Nazaré Correia Soeiro, A.P. Dantas, Anissa Daliry et al. · Memórias do Instituto Oswaldo Cruz · 2009 · 39 citations · Full text

Bioorganic Chemistry, Antiparasitic Agent, Immunology +22

Cerebral microvascular dysfunction in metabolic syndrome is exacerbated by ischemia–reperfusion injury

Nathalie Obadia, Marcos Adriano Lessa, Anissa Daliry et al. · BMC Neuroscience · 2017 · 38 citations · Full text

<p>High-fat diet-induced kidney alterations in rats with metabolic syndrome: endothelial dysfunction and decreased antioxidant defense</p>

Raquel Rangel Silvares, Evelyn Nunes Goulart da Silva Pereira, Edgar Eduardo Ilaquita Flores et al. · Diabetes Metabolic Syndrome and Obesity · 2019 · 38 citations · Full text

In Vitro and In Vivo Investigation of the Efficacy of Arylimidamide DB1831 and Its Mesylated Salt Form - DB1965 - against Trypanosoma cruzi Infection

Cristiane França da Silva, Denise da Gama Jaén Batista, Gabriel Melo de Oliveira et al. · PLoS ONE · 2012 · 37 citations · Full text

Antiparasitic Agent, Trypanosoma Cruzi Infection, Malaria +16